Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Transformational crossing system to prevent amputation and treat complex chronic total occlusions in critical limb ischemia

Ziel

Critical limb Threatening ischemia (CLTI) is caused by chronic total occlusions (CTOs) in the arteries of the lower extremities. Left untreated, the complications of CLTI results in amputation of the affected limb. The prognosis for those diagnosed with CLTI is comparative to an aggressive cancer. At 1 year post diagnosis, 25% of patients will die and 30% had an amputation, 60% are dead by year 5

CTO is caused by the build-up and calcification of plaque inside the artery, blocking the artery and hardens over time and prevents the passage of a guidewire or therapy device through the vessel. Versono has designed and developed a solution to allow an endovascular surgeon to confidently cross 90% of occlusions within 10 mins

This dedicated CTO guidewire uses an acoustic wave (ultrasound) to penetrate through the calcium/plaque and enable physicians to apply other treatments like stents, balloons or atherectomy devices to unblock the CTO and restore blood flow to the tissue downstream.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) HORIZON-EIC-2023-ACCELERATOR-01

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

VERSONO MEDICAL LIMITED
Netto-EU-Beitrag
€ 2 478 175,00
Adresse
PARKMORE WEST BUSINESS PARK
H91 HP4F Galway
Irland
KMU
Ja
Region
Ireland Northern and Western West
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
€ 3 544 625,00